Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 370

1.

Inflammasome Signaling and Impaired Vascular Health in Psoriasis.

Garshick MS, Barrett T, Wechter T, Azarchi S, Scher J, Neimann A, Katz S, Fuentes-Duculan J, Cannizzaro MV, Jelic S, Fisher EA, Krueger JG, Berger JS.

Arterioscler Thromb Vasc Biol. 2019 Feb 14:ATVBAHA118312246. doi: 10.1161/ATVBAHA.118.312246. [Epub ahead of print]

PMID:
30760013
2.

Anti-Inflammatory Effects of a Vegan Diet Versus the American Heart Association-Recommended Diet in Coronary Artery Disease Trial.

Shah B, Newman JD, Woolf K, Ganguzza L, Guo Y, Allen N, Zhong J, Fisher EA, Slater J.

J Am Heart Assoc. 2018 Dec 4;7(23):e011367. doi: 10.1161/JAHA.118.011367.

3.

Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance.

Braza MS, van Leent MMT, Lameijer M, Sanchez-Gaytan BL, Arts RJW, Pérez-Medina C, Conde P, Garcia MR, Gonzalez-Perez M, Brahmachary M, Fay F, Kluza E, Kossatz S, Dress RJ, Salem F, Rialdi A, Reiner T, Boros P, Strijkers GJ, Calcagno CC, Ginhoux F, Marazzi I, Lutgens E, Nicolaes GAF, Weber C, Swirski FK, Nahrendorf M, Fisher EA, Duivenvoorden R, Fayad ZA, Netea MG, Mulder WJM, Ochando J.

Immunity. 2018 Nov 20;49(5):819-828.e6. doi: 10.1016/j.immuni.2018.09.008. Epub 2018 Nov 6.

PMID:
30413362
4.

Severe obesity and bariatric surgery alter the platelet mRNA profile.

Heffron SP, Marier C, Parikh M, Fisher EA, Berger JS.

Platelets. 2018 Nov 2:1-8. doi: 10.1080/09537104.2018.1536261. [Epub ahead of print]

PMID:
30388921
5.

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life.

Robinson JG, Williams KJ, Gidding S, Borén J, Tabas I, Fisher EA, Packard C, Pencina M, Fayad ZA, Mani V, Rye KA, Nordestgaard BG, Tybjærg-Hansen A, Douglas PS, Nicholls SJ, Pagidipati N, Sniderman A.

J Am Heart Assoc. 2018 Oct 16;7(20):e009778. doi: 10.1161/JAHA.118.009778. No abstract available.

6.

Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2).

Moore KJ, Koplev S, Fisher EA, Tabas I, Björkegren JLM, Doran AC, Kovacic JC.

J Am Coll Cardiol. 2018 Oct 30;72(18):2181-2197. doi: 10.1016/j.jacc.2018.08.2147. Review.

PMID:
30360827
7.

Evaluation of Mass Vaccination Clinics in Response to a Serogroup B Meningococcal Disease Outbreak at a Large, Public University-Oregon, 2015.

Fisher EA, Poissant T, Luedtke P, Leman R, Young C, Cieslak P.

J Adolesc Health. 2018 Aug;63(2):151-156. doi: 10.1016/j.jadohealth.2018.03.018.

PMID:
30149923
8.

Elevated GlycA in severe obesity is normalized by bariatric surgery.

Manmadhan A, Lin BX, Zhong J, Parikh M, Berger JS, Fisher EA, Heffron SP.

Diabetes Obes Metab. 2019 Jan;21(1):178-182. doi: 10.1111/dom.13481. Epub 2018 Aug 28.

PMID:
30047224
9.

Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop.

Goldberg IJ, Reue K, Abumrad NA, Bickel PE, Cohen S, Fisher EA, Galis ZS, Granneman JG, Lewandowski ED, Murphy R, Olive M, Schaffer JE, Schwartz-Longacre L, Shulman GI, Walther TC, Chen J.

Circulation. 2018 Jul 17;138(3):305-315. doi: 10.1161/CIRCULATIONAHA.118.033704. Review.

PMID:
30012703
10.

Genome analysis of methicillin resistance in Macrococcus caseolyticus from dairy cattle in England and Wales.

MacFadyen AC, Fisher EA, Costa B, Cullen C, Paterson GK.

Microb Genom. 2018 Aug;4(8). doi: 10.1099/mgen.0.000191. Epub 2018 Jun 19.

11.

Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice.

Yuan C, Hu J, Parathath S, Grauer L, Cassella CB, Bagdasarov S, Goldberg IJ, Ramasamy R, Fisher EA.

Diabetes. 2018 Sep;67(9):1880-1891. doi: 10.2337/db18-0156. Epub 2018 Jun 11.

PMID:
29891593
12.

Insights From Pre-Clinical and Clinical Studies on the Role of Innate Inflammation in Atherosclerosis Regression.

Rahman K, Fisher EA.

Front Cardiovasc Med. 2018 May 11;5:32. doi: 10.3389/fcvm.2018.00032. eCollection 2018.

13.

Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial.

Gianos E, Schoenthaler A, Guo Y, Zhong J, Weintraub H, Schwartzbard A, Underberg J, Schloss M, Newman JD, Heffron S, Fisher EA, Berger JS.

Am Heart J. 2018 May;199:37-43. doi: 10.1016/j.ahj.2017.12.019. Epub 2018 Jan 9.

14.

Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?

Doonan LM, Fisher EA, Brodsky JL.

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Jul;1863(7):762-771. doi: 10.1016/j.bbalip.2018.03.010. Epub 2018 Apr 6. Review.

PMID:
29627384
15.

Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine.

Scolaro B, Nogueira MS, Paiva A, Bertolami A, Barroso LP, Vaisar T, Heffron SP, Fisher EA, Castro IA.

Mol Metab. 2018 May;11:137-144. doi: 10.1016/j.molmet.2018.02.005. Epub 2018 Feb 20.

16.

Changes in lipoprotein(a) following bariatric surgery.

Lin BX, Weiss MC, Parikh M, Berger JS, Fisher EA, Heffron SP.

Am Heart J. 2018 Mar;197:175-176. doi: 10.1016/j.ahj.2017.10.020. Epub 2017 Nov 4. No abstract available.

PMID:
29447779
17.

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.

Seijkens TTP, van Tiel CM, Kusters PJH, Atzler D, Soehnlein O, Zarzycka B, Aarts SABM, Lameijer M, Gijbels MJ, Beckers L, den Toom M, Slütter B, Kuiper J, Duchene J, Aslani M, Megens RTA, van 't Veer C, Kooij G, Schrijver R, Hoeksema MA, Boon L, Fay F, Tang J, Baxter S, Jongejan A, Moerland PD, Vriend G, Bleijlevens B, Fisher EA, Duivenvoorden R, Gerdes N, de Winther MPJ, Nicolaes GA, Mulder WJM, Weber C, Lutgens E.

J Am Coll Cardiol. 2018 Feb 6;71(5):527-542. doi: 10.1016/j.jacc.2017.11.055.

18.

Direct Mapping of Heterogeneous Surface Coverage in DNA-Functionalized Gold Surfaces with Correlated Electron and Fluorescence Microscopy.

Martens I, Fisher EA, Bizzotto D.

Langmuir. 2018 Feb 20;34(7):2425-2431. doi: 10.1021/acs.langmuir.7b03766. Epub 2018 Feb 6.

PMID:
29361826
19.

Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor.

Basu D, Hu Y, Huggins LA, Mullick AE, Graham MJ, Wietecha T, Barnhart S, Mogul A, Pfeiffer K, Zirlik A, Fisher EA, Bornfeldt KE, Willecke F, Goldberg IJ.

Circ Res. 2018 Feb 16;122(4):560-567. doi: 10.1161/CIRCRESAHA.117.311361. Epub 2018 Jan 10.

20.

Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100.

Amengual J, Guo L, Strong A, Madrigal-Matute J, Wang H, Kaushik S, Brodsky JL, Rader DJ, Cuervo AM, Fisher EA.

Circ Res. 2018 Feb 16;122(4):568-582. doi: 10.1161/CIRCRESAHA.117.311240. Epub 2018 Jan 4.

21.

High-Density Lipoprotein Nanobiologics for Precision Medicine.

Mulder WJM, van Leent MMT, Lameijer M, Fisher EA, Fayad ZA, Pérez-Medina C.

Acc Chem Res. 2018 Jan 16;51(1):127-137. doi: 10.1021/acs.accounts.7b00339. Epub 2017 Dec 27.

PMID:
29281244
22.

Changes in High-Density Lipoprotein Cholesterol Efflux Capacity After Bariatric Surgery Are Procedure Dependent.

Heffron SP, Lin BX, Parikh M, Scolaro B, Adelman SJ, Collins HL, Berger JS, Fisher EA.

Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):245-254. doi: 10.1161/ATVBAHA.117.310102. Epub 2017 Nov 21.

23.

Quantifying the Selective Modification of Au(111) Facets via Electrochemical and Electroless Treatments for Manipulating Gold Nanorod Surface Composition.

Fisher EA, Leung KK, Casanova-Moreno J, Masuda T, Young J, Bizzotto D.

Langmuir. 2017 Nov 14;33(45):12887-12896. doi: 10.1021/acs.langmuir.7b03021. Epub 2017 Nov 1.

PMID:
29058912
24.

Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric fah-/- Mice.

Andreo U, de Jong YP, Scull MA, Xiao JW, Vercauteren K, Quirk C, Mommersteeg MC, Bergaya S, Menon A, Fisher EA, Rice CM.

Cell Mol Gastroenterol Hepatol. 2017 Jul 19;4(3):405-417. doi: 10.1016/j.jcmgh.2017.07.002. eCollection 2017 Nov.

25.

Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk.

Barrett TJ, Murphy AJ, Goldberg IJ, Fisher EA.

Ann N Y Acad Sci. 2017 Aug;1402(1):31-42. doi: 10.1111/nyas.13462. Review.

26.

Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr-/- Mice.

Yu M, Amengual J, Menon A, Kamaly N, Zhou F, Xu X, Saw PE, Lee SJ, Si K, Ortega CA, Choi WI, Lee IH, Bdour Y, Shi J, Mahmoudi M, Jon S, Fisher EA, Farokhzad OC.

Adv Healthc Mater. 2017 Oct;6(20). doi: 10.1002/adhm.201700313. Epub 2017 Jul 21.

27.

Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association.

Daugherty A, Tall AR, Daemen MJAP, Falk E, Fisher EA, García-Cardeña G, Lusis AJ, Owens AP 3rd, Rosenfeld ME, Virmani R; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Basic Cardiovascular Sciences.

Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):e131-e157. doi: 10.1161/ATV.0000000000000062. Epub 2017 Jul 20. Review.

PMID:
28729366
28.

Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association.

Daugherty A, Tall AR, Daemen MJAP, Falk E, Fisher EA, García-Cardeña G, Lusis AJ, Owens AP 3rd, Rosenfeld ME, Virmani R; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Basic Cardiovascular Sciences.

Circ Res. 2017 Sep 1;121(6):e53-e79. doi: 10.1161/RES.0000000000000169. Epub 2017 Jul 20. Review.

PMID:
28729353
29.

Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression.

Rahman K, Vengrenyuk Y, Ramsey SA, Vila NR, Girgis NM, Liu J, Gusarova V, Gromada J, Weinstock A, Moore KJ, Loke P, Fisher EA.

J Clin Invest. 2017 Aug 1;127(8):2904-2915. doi: 10.1172/JCI75005. Epub 2017 Jun 26.

30.

Neutrophil-derived S100 calcium-binding proteins A8/A9 promote reticulated thrombocytosis and atherogenesis in diabetes.

Kraakman MJ, Lee MK, Al-Sharea A, Dragoljevic D, Barrett TJ, Montenont E, Basu D, Heywood S, Kammoun HL, Flynn M, Whillas A, Hanssen NM, Febbraio MA, Westein E, Fisher EA, Chin-Dusting J, Cooper ME, Berger JS, Goldberg IJ, Nagareddy PR, Murphy AJ.

J Clin Invest. 2017 Jun 1;127(6):2133-2147. doi: 10.1172/JCI92450. Epub 2017 May 15.

31.

Vitamin A mediates conversion of monocyte-derived macrophages into tissue-resident macrophages during alternative activation.

Gundra UM, Girgis NM, Gonzalez MA, San Tang M, Van Der Zande HJP, Lin JD, Ouimet M, Ma LJ, Poles J, Vozhilla N, Fisher EA, Moore KJ, Loke P.

Nat Immunol. 2017 Jun;18(6):642-653. doi: 10.1038/ni.3734. Epub 2017 Apr 24.

32.

microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.

Ouimet M, Ediriweera H, Afonso MS, Ramkhelawon B, Singaravelu R, Liao X, Bandler RC, Rahman K, Fisher EA, Rayner KJ, Pezacki JP, Tabas I, Moore KJ.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1058-1067. doi: 10.1161/ATVBAHA.116.308916. Epub 2017 Apr 20.

33.

Inflammatory processes in cardiovascular disease: a route to targeted therapies.

Ruparelia N, Chai JT, Fisher EA, Choudhury RP.

Nat Rev Cardiol. 2017 May;14(5):314. doi: 10.1038/nrcardio.2017.33. Epub 2017 Mar 16. No abstract available.

PMID:
28300082
34.

A wild-type mouse-based model for the regression of inflammation in atherosclerosis.

Peled M, Nishi H, Weinstock A, Barrett TJ, Zhou F, Quezada A, Fisher EA.

PLoS One. 2017 Mar 14;12(3):e0173975. doi: 10.1371/journal.pone.0173975. eCollection 2017.

35.

Hyperglycemia enhances arsenic-induced platelet and megakaryocyte activation.

Newman JD, Echagarruga CT, Ogando YM, Montenont E, Chen Y, Fisher EA, Berger JS.

J Transl Med. 2017 Mar 6;15(1):55. doi: 10.1186/s12967-017-1148-1.

36.

Inflammatory processes in cardiovascular disease: a route to targeted therapies.

Ruparelia N, Chai JT, Fisher EA, Choudhury RP.

Nat Rev Cardiol. 2017 Mar;14(3):133-144. doi: 10.1038/nrcardio.2016.185. Epub 2016 Dec 1. Review. Erratum in: Nat Rev Cardiol. 2017 May;14 (5):314.

37.

Immune cell screening of a nanoparticle library improves atherosclerosis therapy.

Tang J, Baxter S, Menon A, Alaarg A, Sanchez-Gaytan BL, Fay F, Zhao Y, Ouimet M, Braza MS, Longo VA, Abdel-Atti D, Duivenvoorden R, Calcagno C, Storm G, Tsimikas S, Moore KJ, Swirski FK, Nahrendorf M, Fisher EA, Pérez-Medina C, Fayad ZA, Reiner T, Mulder WJ.

Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6731-E6740. Epub 2016 Oct 17.

38.

Inflammation-a Critical Appreciation of the Role of Myeloid Cells.

Iqbal AJ, Fisher EA, Greaves DR.

Microbiol Spectr. 2016 Oct;4(5). doi: 10.1128/microbiolspec.MCHD-0027-2016. Review.

39.

A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis.

Xu S, Liu B, Yin M, Koroleva M, Mastrangelo M, Ture S, Morrell CN, Zhang DX, Fisher EA, Jin ZG.

Oncotarget. 2016 Jun 21;7(25):37622-37635. doi: 10.18632/oncotarget.9376.

40.

Ligand Shell Composition-Dependent Effects on the Apparent Hydrophobicity and Film Behavior of Gold Nanoparticles at the Air-Water Interface.

Bradford SM, Fisher EA, Meli MV.

Langmuir. 2016 Sep 27;32(38):9790-6. doi: 10.1021/acs.langmuir.6b02238. Epub 2016 Sep 14.

PMID:
27594307
41.

Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivo.

Iqbal AJ, Barrett TJ, Taylor L, McNeill E, Manmadhan A, Recio C, Carmineri A, Brodermann MH, White GE, Cooper D, DiDonato JA, Zamanian-Daryoush M, Hazen SL, Channon KM, Greaves DR, Fisher EA.

Elife. 2016 Aug 30;5. pii: e15190. doi: 10.7554/eLife.15190.

42.

Divergent JAM-C Expression Accelerates Monocyte-Derived Cell Exit from Atherosclerotic Plaques.

Bradfield PF, Menon A, Miljkovic-Licina M, Lee BP, Fischer N, Fish RJ, Kwak B, Fisher EA, Imhof BA.

PLoS One. 2016 Jul 21;11(7):e0159679. doi: 10.1371/journal.pone.0159679. eCollection 2016.

43.

In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.

Pérez-Medina C, Binderup T, Lobatto ME, Tang J, Calcagno C, Giesen L, Wessel CH, Witjes J, Ishino S, Baxter S, Zhao Y, Ramachandran S, Eldib M, Sánchez-Gaytán BL, Robson PM, Bini J, Granada JF, Fish KM, Stroes ES, Duivenvoorden R, Tsimikas S, Lewis JS, Reiner T, Fuster V, Kjær A, Fisher EA, Fayad ZA, Mulder WJ.

JACC Cardiovasc Imaging. 2016 Aug;9(8):950-61. doi: 10.1016/j.jcmg.2016.01.020. Epub 2016 May 25.

44.

Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia.

Marsch E, Demandt JA, Theelen TL, Tullemans BM, Wouters K, Boon MR, van Dijk TH, Gijbels MJ, Dubois LJ, Meex SJ, Mazzone M, Hung G, Fisher EA, Biessen EA, Daemen MJ, Rensen PC, Carmeliet P, Groen AK, Sluimer JC.

Eur Heart J. 2016 Oct 14;37(39):2993-2997. Epub 2016 Apr 28.

45.

High density lipoprotein and metabolic disease: Potential benefits of restoring its functional properties.

Klancic T, Woodward L, Hofmann SM, Fisher EA.

Mol Metab. 2016 Mar 18;5(5):321-327. doi: 10.1016/j.molmet.2016.03.001. eCollection 2016 May. Review.

46.

Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages.

Shrestha E, Hussein MA, Savas JN, Ouimet M, Barrett TJ, Leone S, Yates JR 3rd, Moore KJ, Fisher EA, Garabedian MJ.

J Biol Chem. 2016 May 20;291(21):11172-84. doi: 10.1074/jbc.M116.726729. Epub 2016 Mar 29.

47.

Genomic Analysis of Companion Rabbit Staphylococcus aureus.

Holmes MA, Harrison EM, Fisher EA, Graham EM, Parkhill J, Foster G, Paterson GK.

PLoS One. 2016 Mar 10;11(3):e0151458. doi: 10.1371/journal.pone.0151458. eCollection 2016.

48.

Regression of Atherosclerosis: The Journey From the Liver to the Plaque and Back.

Fisher EA.

Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):226-35. doi: 10.1161/ATVBAHA.115.301926. Epub 2015 Dec 17. Review.

49.

How an artery heals.

Williams KJ, Tabas I, Fisher EA.

Circ Res. 2015 Nov 6;117(11):909-13. doi: 10.1161/CIRCRESAHA.115.307609. No abstract available.

50.

MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis.

Ouimet M, Ediriweera HN, Gundra UM, Sheedy FJ, Ramkhelawon B, Hutchison SB, Rinehold K, van Solingen C, Fullerton MD, Cecchini K, Rayner KJ, Steinberg GR, Zamore PD, Fisher EA, Loke P, Moore KJ.

J Clin Invest. 2015 Oct 26;125(12):4334-48. doi: 10.1172/JCI81676.

Supplemental Content

Loading ...
Support Center